Access to regulatory data from the European Medicines Agency: the times they are a-changing

Systematic reviewers are increasingly trying to obtain regulatory clinical study reports (CSRs) to correct for publication bias. For instance, our organization, the Institute for Quality and Efficiency in Health Care, routinely asks drug manufacturers to provide full CSRs of studies considered in he...

Descripción completa

Detalles Bibliográficos
Autores principales: Wieseler, Beate, McGauran, Natalie, Kerekes, Michaela F, Kaiser, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495027/
https://www.ncbi.nlm.nih.gov/pubmed/23110993
http://dx.doi.org/10.1186/2046-4053-1-50

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495027/
https://www.ncbi.nlm.nih.gov/pubmed/23110993
http://dx.doi.org/10.1186/2046-4053-1-50

Ejemplares similares